SynthesisFrontiers in immunology2025

The efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy as a first-line treatment for unresectable, locally advanced, HER2-negative gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials.

Wenji Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.